Seeking women with ovarian cancer that progressed after at least 4 cycles of treatment with platinum-based chemotherapy for a study of an investigational drug.
All participants in this study will get the usual treatment for their cancer, but half of the participants will also get the investigational drug.
What we're hoping for
We hope to study whether adding the investigational drug to the usual treatment for platinum-resistant ovarian cancer improves the effectiveness of the usual treatment.
ClinicalTrials.gov Identifier: NCT04374630